Aarti Pharmalabs Ltd. | Mid-cap | Healthcare
₹859.55
-1.52%
| Aarti Pharmalabs Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 21.2B
Gross Profit 9.9B 46.67%
Operating Income 3.8B 17.85%
Net Income 2.7B 12.88%
EPS (Diluted) ₹30.04

Balance Sheet Metrics

Total Assets 29.1B
Total Liabilities 9.2B
Shareholders Equity 19.9B
Debt to Equity 0.46

Cash Flow Metrics

Operating Cash Flow 3.5B
Free Cash Flow -1.1B

Revenue & Profitability Trend

Aarti Pharmalabs Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 21.2B 18.2B 19.4B 11.9B 0
Cost of Goods Sold 11.3B 11.1B 12.5B 8.8B 0
Gross Profit 9.9B 7.0B 6.8B 3.1B 0
Operating Expenses 3.6B 1.7B 1.8B 277.1M 50.0K
Operating Income 3.8B 3.1B 2.8B 1.7B -46.0K
Pre-tax Income 3.6B 3.0B 2.6B 1.6B -46.0K
Income Tax 882.8M 835.9M 672.8M 331.3M 0
Net Income 2.7B 2.2B 1.9B 1.2B -46.0K
EPS (Diluted) ₹30.04 ₹23.93 ₹21.35 ₹13.49 ₹0.00

Income Statement Trend

Aarti Pharmalabs Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 13.2B 13.5B 11.6B 10.3B -
Non-Current Assets 15.8B 12.4B 10.8B 10.1B -
Total Assets 29.1B 25.8B 22.4B 20.4B -
Liabilities
Current Liabilities 6.6B 6.9B 6.0B 5.8B 146.2M
Non-Current Liabilities 2.6B 1.3B 849.1M 727.6M 18.0M
Total Liabilities 9.2B 8.3B 6.9B 6.5B 164.2M
Equity
Total Shareholders Equity 19.9B 17.6B 15.6B 13.9B 827.1M

Balance Sheet Composition

Aarti Pharmalabs Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 3.6B 3.0B 2.6B 1.6B -46.0K
Operating Cash Flow 3.5B 1.5B 1.2B 96.6M 46.0K
Investing Activities
Capital Expenditures -4.0B -1.6B -1.0B -1.4B 0
Investing Cash Flow -4.0B -1.7B -1.4B -1.4B 0
Financing Activities
Dividends Paid -317.2M -181.3M -181.3M - -
Financing Cash Flow -38.5M 318.7M -1.4B 2.7B 0
Free Cash Flow -1.1B 175.7M 1.3B -1.8B 0

Cash Flow Trend

Aarti Pharmalabs Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 28.41
Price to Book 3.89
Price to Sales 3.66
PEG Ratio 1.11

Profitability Ratios

Profit Margin 12.88%
Operating Margin 21.78%
Return on Equity 14.54%
Return on Assets 8.60%

Financial Health

Current Ratio 2.01
Debt to Equity 20.76
Beta -0.42

Per Share Data

EPS (TTM) ₹30.03
Book Value per Share ₹219.62
Revenue per Share ₹233.40

Financial data is updated regularly. All figures are in the company's reporting currency.